PERSPECTIVE THERAPEUTICS INC (CATX) Stock Income Statement
NYSEARCA:CATX - NYSE Arca - US46489V3024 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-6-30) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.47M | 1.45M | 1.43M | 10.80M | 10.05M | |||
| Cost Of Goods | N/A | N/A | N/A | 6.18M | 4.93M | |||
| Gross Profit | N/A | N/A | N/A | 4.62M | 5.12M | |||
| Operating Expenses | 77.09M | 68.25M | 42.38M | 12.01M | 8.56M | |||
| Research and Development | 48.52M | 41.64M | 21.31M | 2.58M | 1.43M | |||
| Selling, General, and Administrative Expenses | 28.58M | 26.61M | 21.06M | 9.43M | 7.13M | |||
| Operating Income | -75.62M | -66.80M | -40.94M | -7.39M | -3.44M | |||
| Interest Income/Expense | 11.53M | 10.46M | 833.00K | 120.00K | 60.00K | |||
| Other Income/Expense | N/A | N/A | 2.00K | N/A | N/A | |||
| Non Recurring Items | N/A | -24.09M | 0.00 | 0.00 | -10.00K | |||
| Income Before Taxes | -86.78M | -80.43M | -40.11M | -7.27M | -3.39M | |||
| Income Tax | N/A | -2.10M | -2.65M | N/A | N/A | |||
| Net Income | -85.17M | -79.28M | -46.51M | -7.27M | -3.39M | |||
| EBITDA | -72.94M | -64.49M | -39.95M | -7.10M | -3.25M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.20 | -1.22 | -1.73 | -0.05 | -0.03 | |||
| Non GAAP EPS | -0.89 | -0.84 | N/A | -0.05 | -0.04 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | 42.78% | 50.95% | |||
| Profit Margin | -5790.07% | -5452.48% | -3243.24% | -67.31% | -33.73% | |||
| Operating Profit Margin | -5140.99% | -4594.02% | -2855.02% | -68.43% | -34.23% | |||
All data in USD